Literature DB >> 21111992

Renal diseases and the liver.

Florence Wong1.   

Abstract

Many liver diseases coexist with chronic renal disease, because many systemic conditions affect both the liver and the kidneys. Certain liver diseases are also common in patients with chronic renal disease, especially viral hepatitis, either because the renal disease occurs as a complication of viral hepatitis, or the viral hepatitis is acquired as a result of dialysis. Renal tubular dysfunction is also frequently observed with cholestasis. However, liver complications of renal diseases are extremely uncommon, notable examples include nephrogenic ascites and nephrogenic hepatic dysfunction. Nephrogenic ascites can mimic liver cirrhosis with ascites, and it improves with renal transplantation. Nephrogenic hepatic dysfunction is a manifestation of renal cell carcinoma, which settles with the removal of the renal cell carcinoma, but returns with the recurrence of the tumor. In general, the presence of liver disease in patients with chronic renal disease makes management of both conditions more challenging. Viral hepatitis should be treated, if possible, before renal transplant. If cirrhosis is present, renal transplant alone is contraindicated; combined liver and kidney transplantation is indicated in patients with end-stage renal disease and advanced cirrhosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21111992     DOI: 10.1016/j.cld.2010.09.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  5 in total

1.  Equal 3-Year Outcomes for Kidney Transplantation Alone in HCV-Positive Patients With Cirrhosis.

Authors:  Afshin Parsikia; Stalin Campos; Kamran Khanmoradi; John Pang; Manjula Balasubramanian; Radi Zaki; Jorge Ortiz
Journal:  Int Surg       Date:  2015-01

2.  Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.

Authors:  Wai Hoong Chang; Stefanie H Mueller; Sheng-Chia Chung; Graham R Foster; Alvina G Lai
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

Review 3.  [Management of decompensated liver cirrhosis in the intensive care unit].

Authors:  O Lerschmacher; A Koch; K Streetz; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-14       Impact factor: 0.840

4.  Icodextrin-associated hepatotoxicity.

Authors:  Ozkan Gungor; Fatih Kircelli; Erhan Tatar; Huseyin Toz
Journal:  NDT Plus       Date:  2011-08

5.  Bacteriologic study of cirrhotic patients with non-neutrocytic ascites.

Authors:  Hossein Dabiri; Masoumeh Azimi Rad; Ramin Tavafzadeh; Effat Taheri; Soudabeh Safakar; Ehsan Nazemalhosseini Mojarad; Neda Farzaneh; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.